ArticleJACS Au2026

A Biomimetic Self-Adjuvanting Glycoprotein Vaccine Platform Elicits Potent Antitumor Immunity against GD2-Positive Cancers.

Dong Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.